🇺🇸 FDA
Patent

US 10287582

Organic compositions to treat HSF1-related diseases

granted A61KA61K31/713A61K45/06

Quick answer

US patent 10287582 (Organic compositions to treat HSF1-related diseases) held by Arrowhead Pharmaceuticals, Inc. expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Pharmaceuticals, Inc.
Grant date
Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/713, A61K45/06, A61P, A61P19/02